Immunotherapy Plus Chemoradiotherapy Boosts Small-Cell Lung Cancer
Limited-stage small-cell lung cancer (LS-SCLC) has long posed a significant therapeutic challenge, with minimal advancements in treatment improving patient outcomes ...
Limited-stage small-cell lung cancer (LS-SCLC) has long posed a significant therapeutic challenge, with minimal advancements in treatment improving patient outcomes ...
In a groundbreaking study published in BioMedical Engineering OnLine, researchers have unveiled compelling evidence supporting the superiority of concurrent chemoradiotherapy ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine